Benign prostate hyperplasia and stem cells: A new therapeutic opportunity

Cell Biology and Toxicology

Volumn 28, Issue 6, 2012, Pages 435-442

  Notara, Maria ^a   Ahmed, Aamir ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Benign prostate hyperplasia; Drug targeting; Stem cells; Stroma

Indexed keywords

ATAXIN 1; CD133 ANTIGEN; CD34 ANTIGEN; MICRORNA 34A;

CELL COMPONENT; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CHRONIC INFLAMMATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; EPITHELIUM CELL; HORMONAL REGULATION; HUMAN; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STROMA CELL; TARGET CELL DESTRUCTION;

HUMANS; INFLAMMATION; LOWER URINARY TRACT SYMPTOMS; MALE; MESENCHYMAL STROMAL CELLS; PROSTATE; PROSTATIC HYPERPLASIA; SIGNAL TRANSDUCTION;

EID: 84872118555     PISSN: 07422091     EISSN: 15736822     Source Type: Journal    
DOI: 10.1007/s10565-012-9234-x     Document Type: Review

References (53)

1. Barclay WW, Woodruff RD, Hall MC, Cramer SD. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology. 2005;146:13-8.
2. Berry SJ, Coffey DS,Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474-9.
3. Berry SJ, Coffey DS, Strandberg JD, Ewing LL. Effect of age, castration, and testosterone replacement on the development and restoration of canine benign prostatic hyperplasia. Prostate. 1986;9:295-302.
4. Burger PE, Xiong XH, Coetzee S, Salm SN, Moscatelli D, Goto K, Wilson EL. Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci U S A. 2005;102:7180-5.
5. Claus S, Berges R, Senge T, Schulze H. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia. J Urol. 1997;158:217-21.
6. Clifford GM, Farmer RDT. Medical therapy for benign prostatic hyperplasia: a review of the literature. Eur Urol. 2000;38:2-19.
7. Cohen RJ, Glezerson G, Taylor LF, Grundle HAJ, Naude JH. The neuroendocrine cell-population of the human prostategland. J Urol. 1993;150:365-8.
8. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65:10946-51.
9. Cunha GR, Lung B. Possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (TFM) mice. J Exp Zool. 1978;205:181-93.
10. Cunha GR, Hayward SW, Dahiya R, Foster BA. Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. Acta Anat. 1996;155:63-72.
11. Dalrymple S, Antony L, Xu Y, Uzgare AR, Arnold JT, Savaugeot J, Sokoll LJ, de Marzo AM, Isaacs JT. Role of Notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells. Cancer Res. 2005;65:9269-79.
12. Doehring CB, Sanda MG, Partin AW, Sauvageot J, Juo H, Beaty TH, Epstein JI, Hill G, Walsh PC. Histopathologic characterization of hereditary benign prostatic hyperplasia. Urology. 1996;48:650-3.
13. Dubrovska A, Elliott J, Salamone RJ, Kim S, Aimone LJ, Walker JR, Watson J, Sauveur-Michel M, Garcia-Echeverria C, Cho CY, Reddy VA, Schultz PG. Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma. Clin Cancer Res. 2010;16:5692-702.
14. Giles GG, Severi G, English DR, McCredie MRE, Macinnis R, Boyle P, Hopper JL. Early growth, adult body size and prostate cancer risk. Int J Cancer. 2003;103:241-5.
15. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A. 2008;105:20882-7.
16. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86:724-31.
17. Huggins C, Scott WW, Heinen JH. Chemical composition of human semen and of the secretions of the prostate and seminal vesicles. Am J Physiol - Leg Content. 1942;136:467-73.
18. Isaacs JT. Prostate stem cells and benign prostatic hyperplasia. Prostate. 2008;68:1025-34.
19. Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl. 1989;2:33-50.
20. Kellokumpulehtinen P. Correlation of embryonic-development and adult neoplastic changes of human-prostate. Eur Urol. 1989;16:386-90.
21. Kramer G, Steiner GE, Handisurya A, Stix U, Haitel A, Knerer B, Gessl A, Lee C, Marberger M. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate. 2002;52:43-58.
22. Kyprianou N, Tu HC, Jacobs SC. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol. 1996;27:668-75.
23. Lee KL, Peehl DM. Molecular and cellular pathogenesis of benign prostatic hyperplasia. J Urol. 2004;172:1784-91.
24. Lilja H, Oldbring J, Rannevik G, Laurell CB. Seminal vesiclesecreted proteins and their reactions during gelation and liquefaction of human-semen. J Clin Investig. 1987;80:281-5.
25. Lin VK, Wang D, Lee IL, Vasquez D, Fagelson JE, McConnell JD. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue. Prostate. 2000;44:193-203.
26. Lin VK, Wang S-Y, Vazquez DV, Xu CC, Zhang S, Tang L. Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property. Prostate. 2007;67:1265-76.
27. Litman HJ, Bhasin S, O'Leary MP, Link CL, McKinlay JB. An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey. BJU Int. 2007;100:321-6.
28. Litvinov IV, Vander Griend DJ, Xu Y, Antony L, Dalrymple SL, Isaacs JT. Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Cancer Res. 2006;66:8598-607.
29. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011;17:211-5.
30. Marks LS, Trieger B, Dorey FJ, Fu YS, Dekernion JB. Morphometry of the prostate. 1. Distribution of tissuecomponents in hyperplastic glands. Urology. 1994;44: 486-92.
31. Marks LS, Partin AW, Dorey FJ, Gormley GJ, Epstein JI, Garris JB, Macairan ML, Shery ED, Santos PB, Stoner E, Dekernion JB. Long-term effects of finasteride on prostate tissue composition. Urology. 1999;53:574-80.
32. Mcneal JE. Regional morphology and pathology of prostate. Am J Clin Pathol. 1968;49:347-57.
33. McNeal J. Pathology of benign prostatic hyperplasia - insight into etiology. Urol Clin N Am. 1990;17:477-86.
34. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma - correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12:897-906.
35. McVary KT. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol. 2005;47:838-45.
36. Nickel JC, Downey J, Young I, Boag S. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int. 1999;84:976-81.
37. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801.
38. Parsons JK, Palazzi-Churas K, Bergstrom J, Barrett-Connor E. Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo Study. J Urol. 2010;184:1040-4.
39. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44(+)alpha 2 beta 1(+) cell population is enriched in tumor-initiating cells. Cancer Res. 2007;67:6796-805.
40. Peters CA, Walsh PC. The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med. 1987;317:599-604.
41. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-7.
42. Price H, McNeal JE, Stamey TA. Evolving patterns of tissue composition in benign prostatic hyperplasia as a function of specimen size. Hum Pathol. 1990;21:578-85.
43. Ravenna L, Lubrano C, Disilverio F, Vacca A, Felli MP, Maroder M, Deramo G, Sciarra F, Frati L, Gulino A, Petrangeli E. Androgenic and antiandrogenic control on epidermal growth-factor, epidermal growth-factor receptor, and androgen receptor expression in human prostate-cancer cell-line LNCaP. Prostate. 1995;26:290-8.
44. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci. 2004;117:3539-45.
45. Roufosse CA, Direkze NC, Otto WR, Wright NA. Circulating mesenchymal stem cells. Int J Biochem Cell Biol. 2004;36:585-97.
46. Schuster GA, Schuster TG. The relative amount of epithelium, muscle, connective tissue and lumen in prostatic hyperplasia as a function of the mass of tissue resected. J Urol. 1999;161:1168-73.
47. Shapiro E, Becich MJ, Hartanto V, Lepor H. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. J Urol. 1992;147:1293-7.
48. Sufrin G, Heston WDW, Hazra T, Coffey DS. Effect of radiation on prostatic growth. Investig Urol. 1976;13:418-23.
49. Tsujimura A, Koikawa Y, Salm S, Takao T, Coetzee S, Moscatelli D, Shapiro E, Lepor H, Sun TT, Wilson EL. Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol. 2002;157: 1257-65.
50. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, Fuchs E. Defining the epithelial stem cell niche in skin. Science. 2004;303:359-63.
51. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male. 2002;5:98-102.
52. Weisser H, Krieg M. Fatty acid composition of phospholipids in epithelium and stroma of human benign prostatic hyperplasia. Prostate. 1998;36:235-43.
53. Xin L, Lukacs RU, Lawson DA, Cheng D, Witte ON. Selfrenewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells. 2007;25:2760-9.